Genzyme recalls drug on failed stability testing InPharm Sanofi subsidiary Genzyme has recalled nine lots of its transplant drug Thymoglobulin in the US after stability testing revealed there may be a quality issue with the product. The affected lots of Thymoglobulin (anti-thymocyte Globulin [Rabbit]) are ... |
